URGN UroGen Pharma Ltd.

NASDAQ
$42.31

UroGen Pharma Ltd. (URGN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus URGN's own trailing one-year pace, with 25% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
7 transactions
Purchases
$0
0 shares
Sales
$4.1M
98,289 shares
Net activity
-$4.1M
purchases less sales

How much of that selling was preplanned? 25% planned / 75% discretionary

10b5-1 plan sales $1.1M 3 transactions · 30,000 shares
Discretionary sales $3.1M 4 transactions · 68,289 shares

Largest single sale: $2.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Smith Jason Drew General Counsel Sell 1,519 $42.54 $64.6K 53,141 −2.8% of holding
Schoenberg Mark Chief Medical Officer Sell 871 $42.92 $37.4K 59,882 −1.4% of holding
Schoenberg Mark Chief Medical Officer Sell 60,677 $47.05 $2.9M 59,086 −50.7% of holding
Schoenberg Mark Chief Medical Officer Sell 10b5-1 10,000 $40.00 $400.0K 119,763 −7.7% of holding
Schoenberg Mark Chief Medical Officer Sell 10b5-1 10,000 $35.01 $350.1K 129,763 −7.2% of holding
Schoenberg Mark Chief Medical Officer Sell 5,222 $27.30 $142.6K 139,763 −3.6% of holding
Schoenberg Mark Chief Medical Officer Sell 10b5-1 10,000 $30.00 $300.0K 134,985 −6.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.